Intracellular activity of trovafloxacin against Staphylococcus aureus (Q44771568)

6 December 2017

title

Intracellular activity of trovafloxacin against Staphylococcus aureus (English)

1 reference

6 December 2017

main subject

Staphylococcus aureus

1 reference

van den Broek PJ

1

1 reference

6 December 2017

Koot TG

series ordinal

2

1 reference

6 December 2017

van Strijen E

series ordinal

3

1 reference

6 December 2017

Mattie H

series ordinal

4

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 August 1999

1 reference

Journal of Antimicrobial Chemotherapy

6 December 2017

published in

1 reference

6 December 2017

volume

44

1 reference

6 December 2017

issue

2

1 reference

6 December 2017

page(s)

193-199

1 reference

Effect of ciprofloxacin on intracellular organisms: in-vitro and in-vivo studies.

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Uptake and intracellular activity of sparfloxacin in human polymorphonuclear leukocytes and tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Intracellular penetration and activity of BAY Y 3118 in human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Cellular uptake, localization and activity of fluoroquinolones in uninfected and infected macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Ciprofloxacin for treatment of malakoplakia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

In vitro investigation of the intraphagocytic bioactivities of ciprofloxacin and the new fluoroquinolone agents, clinafloxacin (CI-960) and PD 131628.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

In vitro antimycobacterial activity of a new quinolone, levofloxacin (DR-3355).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Comparison of activities of fluoroquinolones in murine macrophages infected with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

The modelling of drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJAC%2F44.2.193

21 January 2018

Identifiers

DOI

10.1093/JAC/44.2.193

1 reference

6 December 2017

1 reference